HOME › DRUGS › BROMFENAC SODIUM
ACTIVE SUBSTANCE / INN

BROMFENAC SODIUM

Brand name(s): BROMDAY, PROLENSA, BROMFENAC SODIUM, XIBROM, BROMSITE
FDA LISTED
PRESCRIPTION
DISCONTINUED
NDA206911
ANDA202030
ACTIVE SUBSTANCE
Bromfenac Sodium
REGULATORS
FDA
SPONSORS / MAH
EUGIA PHARMA, AMRING PHARMS, BAUSCH AND LOMB
TOTAL APPLICATIONS
6
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
BROMFENAC SODIUMANDA202030AMRING PHARMSDiscontinued
BROMFENAC SODIUMANDA204813EUGIA PHARMAPrescription
PROLENSANDA203168BAUSCH AND LOMBPrescription
BROMDAYNDA021664BAUSCH AND LOMB INCDiscontinued
XIBROMNDA021664BAUSCH AND LOMB INCDiscontinued
BROMSITENDA206911SUN PHARMPrescription

FULL INTELLIGENCE ON BROMFENAC SODIUM

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →